4.8 Article

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6

期刊

FRONTIERS IN IMMUNOLOGY
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2017.01521

关键词

phosphatidylserine; Tyro3; Axl; Mertk receptors; growth arrest-specific 6; vitamin K; gamma-carboxylation; tumor exosomes

资金

  1. NIH [NS046593, CA 165077]
  2. grant New Jersey Research Scholars award

向作者/读者索取更多资源

The Tyro3, Axl, and Mertk (TAM) receptors are homologous type I receptor tyrosine kinases that have critical functions in the clearance of apoptotic cells in multicellular organisms. TAMs are activated by their endogenous ligands, growth arrest-specific 6 (Gas6), and protein S (Pros1), that function as bridging molecules between externalized phosphatidylserine (PS) on apoptotic cells and the TAM ectodomains. However, the molecular mechanisms by which Gas6/Pros1 promote TAM activation remains elusive. Using TAM/IFN gamma R1 reporter cell lines to monitor functional TAM activity, we found that Gas6 activity was exquisitely dependent on vitamin K-mediated gamma-carboxylation, whereby replacing vitamin K with anticoagulant warfarin, or by substituting glutamic acid residues involved in PS binding, completely abrogated Gas6 activity as a TAM ligand. Furthermore, using domain and point mutagenesis, Gas6 activity also required both an intact Gla domain and intact EGF-like domains, suggesting these domains function cooperatively in order to achieve TAM activation. Despite the requirement of gamma-carboxylation and the functional Gla domain, non-gamma-carboxylated Gas6 and Gla deletion/EGF-like domain deletion mutants still retained their ability to bind TAMs and acted as blocking decoy ligands. Finally, we found that distinct sources of PS-positive cells/vesicles (including apoptotic cells, calcium-induced stressed cells, and exosomes) bound Gas6 and acted as cell-derived or exosome-derived ligands to activate TAMs. Taken together, our findings indicate that PS is indispensable for TAM activation by Gas6, and by inference, provides new perspectives on how PS, regulates TAM receptors and efferocytosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Meeting Abstract Oncology

Small molecule Axl Ig1-Gas6 inhibitors block Gas6-inducible Axl signaling and suppress tumorigenicity

Nitu Bansal, Stanley Kimani, Kamlendra Singh, Thomas Comollo, Sushi Kumar, Vladyslav Kholodovych, Youyi Peng, William Welsh, Bertino Joseph, Raymond B. Birge

CANCER RESEARCH (2016)

Article Cell Biology

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase

Stanley G. Kimani, Sushil Kumar, Viralkumar Davra, Yun-Juan Chang, Canan Kasikara, Ke Geng, Wen-I Tsou, Shenyan Wang, Mainul Hoque, Andrej Bohac, Anita Lewis-Antes, Mariana S. De Lorenzo, Sergei V. Kotenko, Raymond B. Birge

CELL COMMUNICATION AND SIGNALING (2016)

Editorial Material Biochemistry & Molecular Biology

Efferocytosis

Sushil Kumar, Raymond B. Birge

CURRENT BIOLOGY (2016)

Review Oncology

Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response

Viralkumar Davra, Stanley G. Kimani, David Calianese, Raymond B. Birge

CANCERS (2016)

Review Immunology

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment

Sushil Kumar, David Calianese, Raymond B. Birge

IMMUNOLOGICAL REVIEWS (2017)

Article Oncology

Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis

Sushil Kumar, Bin Lu, Viralkumar Davra, Peter Hornbeck, Kazuya Machida, Raymond B. Birge

MOLECULAR CANCER RESEARCH (2018)

Article Oncology

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani, Wen-I Tsou, Ke Geng, Viralkumar Davra, Ganapathy Sriram, Connor Devoe, Khanh-Quynh N. Nguyen, Anita Antes, Allen Krantz, Grzegorz Rymarczyk, Andrzej Wilczynski, Cyril Empig, Bruce Freimark, Michael Gray, Kyle Schlunegger, Jeff Hutchins, Sergei V. Kotenko, Raymond B. Birge

MOLECULAR CANCER RESEARCH (2017)

Article Multidisciplinary Sciences

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity

Stanley G. Kimani, Sushil Kumar, Nitu Bansal, Kamalendra Singh, Vladyslav Kholodovych, Thomas Comollo, Youyi Peng, Sergei V. Kotenko, Stefan G. Sarafianos, Joseph R. Bertino, William J. Welsh, Raymond B. Birge

SCIENTIFIC REPORTS (2017)

Meeting Abstract Oncology

Non-canonical role of TAM receptors in breast cancer

Shelly Hsieh, Khanh Q. Nguyen, Stanley Kimani, Raymond B. Birge

CANCER RESEARCH (2014)

Meeting Abstract Oncology

Novel Ig1 inhibitors of the Axl tyrosine kinase that block Gas6-inducible receptor activation

William J. Welsh, Vladyslav Kholodovych, Raymond Birge, Tom Comollo, Stanley Kimani, Kamal Singh

CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity

Khanh-Quynh N. Nguyen, Wen-I Tsou, Daniel A. Calarese, Stanley G. Kimani, Sukhwinder Singh, Shelly Hsieh, Yongzhang Liu, Bin Lu, Yi Wu, Scott J. Garforth, Steve C. Almo, Sergei V. Kotenko, Raymond B. Birge

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Chemistry, Organic

Synthesis and Characterization of Mono-, Di-, and Tri-Poly(ethylene glycol) Chlorin e6 Conjugates for the Photokilling of Human Ovarian Cancer Cells

Stanley Kimani, Goutam Ghosh, Ashwini Ghogare, Benjamin Rudshteyn, Dorota Bartusik, Tayyaba Hasan, Alexander Greer

JOURNAL OF ORGANIC CHEMISTRY (2012)

Article Immunology

Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity

Stanley Gititu Kimani, Ke Geng, Canan Kasikara, Sushil Kumar, Ganapathy Sriram, Yi Wu, Raymond B. Birge

FRONTIERS IN IMMUNOLOGY (2014)

暂无数据